Report: Biotech industry more global, headed toward profitability

06/1/2005 | Reuters · Pittsburgh Post-Gazette

In its search for new markets and lower costs, the industry is becoming increasingly internationalized through cross-border alliances, mergers and acquisitions, according to a new report, "Beyond Borders," from Ernst & Young. The same report notes the industry lost a collective $6.4 billion last year, but the promise of about 365 drugs in the last stages of development should make the industry as a whole profitable by 2009.

View Full Article in:

Reuters · Pittsburgh Post-Gazette

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ